HYPERANDROGENISM OF PUBERTY AGE AS A FACTOR REDUCING FERTILITY
https://doi.org/10.20538/1682-0363-2016-1-14-21
Abstract
Aim. Hyperandrogenism is a common cause of infertility in women. The onset of symptoms of hyperandrogenism takes place during puberty in the majority of women. Hyperandrogenism reduces reproductive potential,so early detection and development of its prognostic factors, allows us to solve serious problems of puberty and prevent infertility.
Materials and methods. 113 adolescent girls with hyperandrogenism from 14 to 19 years were included. The control group consists of 25 healthy girls of a similar age. To confirm the prediction of decreased reproductive capacity were examined 35 women with hyperandrogenism from 19 to 36 years. In addition to routine methods of examination (anamnesis, physical examination, anthropometry, assessment of the hairline using Ferriman – Gallwey scale, ultrasound of the pelvic organs, the definition of the hormonal status (LH, FSH, prolactin, 17-OHP, estradiol, TSH, DHEAS-s, GHPG, testosterone), glucose, insulin, glucose tolerance test and dexamethasone suppression test when necessary.
Results. We have proved the reduction of reproductive potential of adolescent girls with high free androgen index (FAI). When the FAI has increased from 36 to 100 conventional units it caused reduction of the reproductive capacity in 9.7 times in comparison with control group (χ2=56,24; p < 0.001; overall prediction accuracy of 92.8%).
Conclusion. Free androgen index more than 36 conventional units is a high risk factor of reduced fertility.
About the Authors
E. M. BogatyrevaRussian Federation
St.-Petersburg State Pediatric Medical University. St.-Petersburg, Russian Federation
G. A. Novik
Russian Federation
St.-Petersburg State Pediatric Medical University. St.-Petersburg, Russian Federation
G. F. Kutusheva
Russian Federation
St.-Petersburg State Pediatric Medical University. St.-Petersburg, Russian Federation
References
1. Kudinova E.G. Narushenija menstrual’noj funkcii uцdevochek-podrostkov i vozmozhnosti ih profilaktiki. Avtoref. dis. kand. med. nauk [Disorders of menstrual function in adolescent girls and their possible prevention. Diss. Cand. med. Sci.]. Barnaul, 2007. 136 p. (in Russian).
2. Kulakov V.I., Prilepskaja V.N., Radzinskij V.E. Rukovodstvo po ambulatorno-poliklinicheskoj pomoshhi v akusherstve i ginekologii [Guidelines for outpatient care in obstetrics and gynecology]. Moscow, GJeOTAR-Media Publ., 2007, pp. 424–435.
3. GurkinYu.A. Detskaja i podrostkovaja ginekologija [The children and adolescent gynecology]. Moscow, MIA Publ., 2009. 698 p. (in Russian).
4. Uvarova E.V. Patogeneticheskie aspekty i sovremennye vozmozhnosti korrekcii giperandrogennyh projavlenij u devochek-podrostkov [Pathogenetic aspects and modern possibilities of correction of hyperandrogenic symptoms in adolescent girls]. Lechashchiy vrach, 2008, no. 3, pp. 75–89 (in Russian).
5. Khamoshina M.B. Korrekcija giperandrogennyh sostojanij – praktika ginekologa [Correction hyperandrogenic States – practice gynecologist]. Ginekologiya – Gynecology, 2010 (ekstravypusk) (in Russian).
6. Vikhlyaeva E.M. Rukovodstvo po jendokrinnoj ginekologii [Guide endocrine gynecology]. Moscow, MIA Publ., 1997. 768 p. (in Russian).
7. Dedov I.I., Andreeva E.N., Karpova E.A. Sindrom polikistoznyh jaichnikov [Polycystic ovary syndrome]. M., ITM Publ., 2009. 52 p. (in Russian).
8. Conway G.S. et al. Risk factors for coronary artery disease in lean and obese women with polycystic ovary syndrome // Clin. Endocrinol. (Oxf). 1992. V. 37. Р. 119–125.
9. Wild R.A., Alaupovic P., Parcer I.G. Lipid and apolipoprotein abnormalities in hirsute women // Am. G. Obstet. Gynecol. 1992. V. 166, № 4. P. 1191–1196.
10. Shilin D.E. Korrekcija metabolicheskih i jendokrinnyh narushenij pri lechenii giperandrogenii u devochek i devushek [Correction of metabolic and endocrine disorders in the treatment of hyperandrogenism in girls and young women]. Farmateka, 2003, no. 16, pp. 51–58.
11. Demidov V.N., Alieva Je.A., Strukov A.V. Vozmozhnosti jehografii v diagnostike sindroma polikistoznyh jaichnikov [The possibility of ultrasoundin the diagnosticsof polycystic ovary syndrome]. Akusherstvo I ginekologiya – Obstetrics and Gynecology, 1991, no.1, pp. 40–42 (in Russian).
12. Chubkin I.V. Metabolicheskij sindrom u devushek podrostkovogo perioda. Avtoref. dis. kand. med. nauk [Metabolic syndrome in girls adolescence. Diss. Cand. med. Sci.] Saint-Petersburg, 2007. 23 p.
13. Gevorkyan M.A., Manukhin I.B., Studenaja L.B. Sindrom polikistoznyh jaichnikov [Polycystic ovary syndrome]. M., ORZhIN Publ., 2008. 32 p. (in Russian).
14. Sultan C. Clinical expression of polycystic ovarian disease in the adolescent // Horm. Res. 2005. V.64, № 1. P. 4.
15. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop Group. / Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome // Fertil. Steril. 2004. V. 81. P. 9–25.
Review
For citations:
Bogatyreva E.M., Novik G.A., Kutusheva G.F. HYPERANDROGENISM OF PUBERTY AGE AS A FACTOR REDUCING FERTILITY. Bulletin of Siberian Medicine. 2016;15(1):14-21. (In Russ.) https://doi.org/10.20538/1682-0363-2016-1-14-21